| Schedule of Finite-Lived Intangible Assets |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | The following summarizes the components of Identifiable intangible assets: | | | March 29, 2026 | | December 31, 2025 | | (MILLIONS) | | Gross
Carrying
Amount | | Accumulated
Amortization | | Identifiable Intangible Assets, Net | | Gross
Carrying
Amount | | Accumulated
Amortization | | Identifiable Intangible Assets, Net | | Finite-lived intangible assets | | | | | | | | | | | | | Developed technology rights(a) | | $ | 101,396 | | | $ | (71,491) | | | $ | 29,905 | | | $ | 100,630 | | | $ | (70,172) | | | $ | 30,458 | | | Brands | | 1,035 | | | (1,035) | | | — | | | 1,035 | | | (1,035) | | | — | | | Licensing agreements and other | | 2,350 | | | (1,336) | | | 1,013 | | | 2,341 | | | (1,289) | | | 1,052 | | | | | | | | | | | | | | | | | 104,780 | | | (73,862) | | | 30,918 | | | 104,006 | | | (72,496) | | | 31,510 | | | Indefinite-lived intangible assets | | | | | | | | | | | | | | | | | | | | | | | | | | IPR&D(a) | | 21,180 | | | | | 21,180 | | | 21,760 | | | | | 21,760 | | Licensing agreements and other | | 460 | | | | | 460 | | | 460 | | | | | 460 | | | | 21,641 | | | | | 21,641 | | | 22,221 | | | | | 22,221 | | Identifiable intangible assets | | $ | 126,421 | | | $ | (73,862) | | | $ | 52,559 | | | $ | 126,227 | | | $ | (72,496) | | | $ | 53,731 | |
(a)The gross carrying amounts reflect a transfer of $580 million from IPR&D to developed technology rights for Tukysa (tucatinib).
|
| Schedule of Indefinite Lived Intangible Assets |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | The following summarizes the components of Identifiable intangible assets: | | | March 29, 2026 | | December 31, 2025 | | (MILLIONS) | | Gross
Carrying
Amount | | Accumulated
Amortization | | Identifiable Intangible Assets, Net | | Gross
Carrying
Amount | | Accumulated
Amortization | | Identifiable Intangible Assets, Net | | Finite-lived intangible assets | | | | | | | | | | | | | Developed technology rights(a) | | $ | 101,396 | | | $ | (71,491) | | | $ | 29,905 | | | $ | 100,630 | | | $ | (70,172) | | | $ | 30,458 | | | Brands | | 1,035 | | | (1,035) | | | — | | | 1,035 | | | (1,035) | | | — | | | Licensing agreements and other | | 2,350 | | | (1,336) | | | 1,013 | | | 2,341 | | | (1,289) | | | 1,052 | | | | | | | | | | | | | | | | | 104,780 | | | (73,862) | | | 30,918 | | | 104,006 | | | (72,496) | | | 31,510 | | | Indefinite-lived intangible assets | | | | | | | | | | | | | | | | | | | | | | | | | | IPR&D(a) | | 21,180 | | | | | 21,180 | | | 21,760 | | | | | 21,760 | | Licensing agreements and other | | 460 | | | | | 460 | | | 460 | | | | | 460 | | | | 21,641 | | | | | 21,641 | | | 22,221 | | | | | 22,221 | | Identifiable intangible assets | | $ | 126,421 | | | $ | (73,862) | | | $ | 52,559 | | | $ | 126,227 | | | $ | (72,496) | | | $ | 53,731 | |
(a)The gross carrying amounts reflect a transfer of $580 million from IPR&D to developed technology rights for Tukysa (tucatinib).
|